Intriguingly, investigation of the cross-talk genes revealed several known melanoma associated biomarkers, including NRAS, PTEN, SRC and RAF1. The occurrences of the biomarkers together in multiple cross-talk events provide the necessary explanation of its potential anti-melanoma drug target activity. The gene discussed is NRAS; the disease is melanoma.